Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash to Debt 12.51
ICAD's Cash to Debt is ranked higher than
51% of the 1813 Companies
in the Global Software - Application industry.

( Industry Median: 9.50 vs. ICAD: 12.51 )
Ranked among companies with meaningful Cash to Debt only.
ICAD' s Cash to Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.89 Max: No Debt
Current: 12.51
Equity to Asset 0.67
ICAD's Equity to Asset is ranked higher than
59% of the 1721 Companies
in the Global Software - Application industry.

( Industry Median: 0.61 vs. ICAD: 0.67 )
Ranked among companies with meaningful Equity to Asset only.
ICAD' s Equity to Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.70 Max: 0.92
Current: 0.67
0.25
0.92
F-Score: 5
Z-Score: -3.21
M-Score: -5.60
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -57.77
ICAD's Operating margin (%) is ranked lower than
89% of the 1767 Companies
in the Global Software - Application industry.

( Industry Median: 4.80 vs. ICAD: -57.77 )
Ranked among companies with meaningful Operating margin (%) only.
ICAD' s Operating margin (%) Range Over the Past 10 Years
Min: -129.54  Med: -13.35 Max: 12.71
Current: -57.77
-129.54
12.71
Net-margin (%) -63.98
ICAD's Net-margin (%) is ranked lower than
89% of the 1768 Companies
in the Global Software - Application industry.

( Industry Median: 3.28 vs. ICAD: -63.98 )
Ranked among companies with meaningful Net-margin (%) only.
ICAD' s Net-margin (%) Range Over the Past 10 Years
Min: -131.18  Med: -23.54 Max: 11.62
Current: -63.98
-131.18
11.62
ROE (%) -58.90
ICAD's ROE (%) is ranked lower than
89% of the 1714 Companies
in the Global Software - Application industry.

( Industry Median: 6.10 vs. ICAD: -58.90 )
Ranked among companies with meaningful ROE (%) only.
ICAD' s ROE (%) Range Over the Past 10 Years
Min: -68.8  Med: -8.91 Max: 7.57
Current: -58.9
-68.8
7.57
ROA (%) -39.99
ICAD's ROA (%) is ranked lower than
88% of the 1814 Companies
in the Global Software - Application industry.

( Industry Median: 3.08 vs. ICAD: -39.99 )
Ranked among companies with meaningful ROA (%) only.
ICAD' s ROA (%) Range Over the Past 10 Years
Min: -51.56  Med: -7.47 Max: 6.46
Current: -39.99
-51.56
6.46
ROC (Joel Greenblatt) (%) -807.56
ICAD's ROC (Joel Greenblatt) (%) is ranked lower than
90% of the 1784 Companies
in the Global Software - Application industry.

( Industry Median: 22.73 vs. ICAD: -807.56 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ICAD' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1592.49  Med: -230.71 Max: 178.33
Current: -807.56
-1592.49
178.33
Revenue Growth (3Y)(%) 5.90
ICAD's Revenue Growth (3Y)(%) is ranked higher than
54% of the 1332 Companies
in the Global Software - Application industry.

( Industry Median: 5.10 vs. ICAD: 5.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ICAD' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -27.8  Med: -2.45 Max: 31.4
Current: 5.9
-27.8
31.4
EPS Growth (3Y)(%) -72.50
ICAD's EPS Growth (3Y)(%) is ranked lower than
97% of the 1004 Companies
in the Global Software - Application industry.

( Industry Median: 5.90 vs. ICAD: -72.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ICAD' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -72.5  Med: -7.45 Max: 59
Current: -72.5
-72.5
59
» ICAD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

ICAD Guru Trades in Q1 2015

Jim Simons 305,060 sh (+11.43%)
» More
Q2 2015

ICAD Guru Trades in Q2 2015

Jim Simons 452,042 sh (+48.18%)
» More
Q3 2015

ICAD Guru Trades in Q3 2015

Jim Simons 353,860 sh (-21.72%)
» More
Q4 2015

ICAD Guru Trades in Q4 2015

Jim Simons 421,099 sh (+19.00%)
» More
» Details

Insider Trades

Latest Guru Trades with ICAD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 25.32
ICAD's Forward P/E is ranked lower than
70% of the 542 Companies
in the Global Software - Application industry.

( Industry Median: 17.39 vs. ICAD: 25.32 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 1.74
ICAD's P/B is ranked higher than
61% of the 1662 Companies
in the Global Software - Application industry.

( Industry Median: 2.30 vs. ICAD: 1.74 )
Ranked among companies with meaningful P/B only.
ICAD' s P/B Range Over the Past 10 Years
Min: 0.43  Med: 1.64 Max: 6.59
Current: 1.74
0.43
6.59
P/S 1.24
ICAD's P/S is ranked higher than
60% of the 1715 Companies
in the Global Software - Application industry.

( Industry Median: 1.71 vs. ICAD: 1.24 )
Ranked among companies with meaningful P/S only.
ICAD' s P/S Range Over the Past 10 Years
Min: 0.76  Med: 2.64 Max: 9.3
Current: 1.24
0.76
9.3
PFCF 27.36
ICAD's PFCF is ranked lower than
61% of the 764 Companies
in the Global Software - Application industry.

( Industry Median: 21.65 vs. ICAD: 27.36 )
Ranked among companies with meaningful PFCF only.
ICAD' s PFCF Range Over the Past 10 Years
Min: 4.37  Med: 24.03 Max: 291.43
Current: 27.36
4.37
291.43
POCF 16.65
ICAD's POCF is ranked lower than
52% of the 976 Companies
in the Global Software - Application industry.

( Industry Median: 15.74 vs. ICAD: 16.65 )
Ranked among companies with meaningful POCF only.
ICAD' s POCF Range Over the Past 10 Years
Min: 4.09  Med: 21.70 Max: 357.5
Current: 16.65
4.09
357.5
Current Ratio 2.05
ICAD's Current Ratio is ranked higher than
52% of the 1707 Companies
in the Global Software - Application industry.

( Industry Median: 2.00 vs. ICAD: 2.05 )
Ranked among companies with meaningful Current Ratio only.
ICAD' s Current Ratio Range Over the Past 10 Years
Min: 0.57  Med: 1.84 Max: 3.85
Current: 2.05
0.57
3.85
Quick Ratio 1.79
ICAD's Quick Ratio is ranked lower than
52% of the 1707 Companies
in the Global Software - Application industry.

( Industry Median: 1.88 vs. ICAD: 1.79 )
Ranked among companies with meaningful Quick Ratio only.
ICAD' s Quick Ratio Range Over the Past 10 Years
Min: 0.44  Med: 1.20 Max: 3.33
Current: 1.79
0.44
3.33
Days Inventory 74.44
ICAD's Days Inventory is ranked lower than
82% of the 1036 Companies
in the Global Software - Application industry.

( Industry Median: 16.83 vs. ICAD: 74.44 )
Ranked among companies with meaningful Days Inventory only.
ICAD' s Days Inventory Range Over the Past 10 Years
Min: 59  Med: 110.39 Max: 236
Current: 74.44
59
236
Days Sales Outstanding 65.71
ICAD's Days Sales Outstanding is ranked higher than
53% of the 1432 Companies
in the Global Software - Application industry.

( Industry Median: 68.31 vs. ICAD: 65.71 )
Ranked among companies with meaningful Days Sales Outstanding only.
ICAD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.34  Med: 66.23 Max: 88.93
Current: 65.71
50.34
88.93
Days Payable 41.32
ICAD's Days Payable is ranked lower than
53% of the 1301 Companies
in the Global Software - Application industry.

( Industry Median: 44.37 vs. ICAD: 41.32 )
Ranked among companies with meaningful Days Payable only.
ICAD' s Days Payable Range Over the Past 10 Years
Min: 93.06  Med: 126.28 Max: 334.69
Current: 41.32
93.06
334.69

Valuation & Return

vs
industry
vs
history
Price/Net Cash 191.50
ICAD's Price/Net Cash is ranked lower than
96% of the 541 Companies
in the Global Software - Application industry.

( Industry Median: 9.67 vs. ICAD: 191.50 )
Ranked among companies with meaningful Price/Net Cash only.
ICAD' s Price/Net Cash Range Over the Past 10 Years
Min: 5.99  Med: 12.36 Max: 279.38
Current: 191.5
5.99
279.38
Price/Net Current Asset Value 4.56
ICAD's Price/Net Current Asset Value is ranked higher than
58% of the 1080 Companies
in the Global Software - Application industry.

( Industry Median: 5.81 vs. ICAD: 4.56 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ICAD' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 3.03  Med: 16.38 Max: 1010
Current: 4.56
3.03
1010
Price/Tangible Book 3.79
ICAD's Price/Tangible Book is ranked lower than
54% of the 1414 Companies
in the Global Software - Application industry.

( Industry Median: 3.42 vs. ICAD: 3.79 )
Ranked among companies with meaningful Price/Tangible Book only.
ICAD' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.76  Med: 9.29 Max: 322.5
Current: 3.79
2.76
322.5
Price/Projected FCF 10.63
ICAD's Price/Projected FCF is ranked lower than
93% of the 696 Companies
in the Global Software - Application industry.

( Industry Median: 1.50 vs. ICAD: 10.63 )
Ranked among companies with meaningful Price/Projected FCF only.
ICAD' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.95  Med: 3.86 Max: 84.17
Current: 10.63
0.95
84.17
Price/Median PS Value 0.48
ICAD's Price/Median PS Value is ranked higher than
89% of the 1359 Companies
in the Global Software - Application industry.

( Industry Median: 1.01 vs. ICAD: 0.48 )
Ranked among companies with meaningful Price/Median PS Value only.
ICAD' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.32  Med: 1.14 Max: 8.22
Current: 0.48
0.32
8.22
Earnings Yield (Greenblatt) (%) -66.70
ICAD's Earnings Yield (Greenblatt) (%) is ranked lower than
95% of the 1751 Companies
in the Global Software - Application industry.

( Industry Median: 2.90 vs. ICAD: -66.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ICAD' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.3  Med: 1.50 Max: 19.2
Current: -66.7
0.3
19.2

More Statistics

Revenue(Mil) $47
EPS $ -1.92
Beta1.63
Short Percentage of Float0.33%
52-Week Range $2.95 - 11.14
Shares Outstanding(Mil)15.73

Analyst Estimate

Dec15
Revenue(Mil)
EPS($) 0.18
EPS without NRI($) 0.18

Business Description

Industry: Application Software » Software - Application
Compare:CRM, SQI, RHT, INTU, ADBE » details
Traded in other countries:HWT1.Germany,
icad Inc was incorporated in the State of Delaware on February 24, 1984. The Company is a provider of image analysis and workflow solutions that enable radiologists and other healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier. It high-performance, expandable Computer-Aided Detection (CAD) systems and workflow solutions for mammography, such as film-based, digital radiography (DR), in addition to computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). It offers a comprehensive range of high-performance upgradeable products for use with mammography, including digital radiography, computed radiography and film-based mammography. These solutions enable radiologists to serve patients by identifying pathologies and pinpointing cancers. The company's solutions aid in the early detection of the prevalent cancers including breast, prostate and colon cancer. Early detection of cancer is the key to prognosis, less invasive and lower treatment costs, and higher survival rates. The company's products are manufactured and assembled for it by a contract manufacturer of medical devices. Its manufacturing efforts are generally limited to purchasing and supply chain management, planning/scheduling, manufacturing engineering, service repairs, quality assurance, inventory management, and warehousing. Its products are sold through its direct regional sales organization in the U.S. as well as through its OEM partners, including GE Healthcare, Fuji Medical Systems, Siemens Medical, Philips Healthcare, Agfa Corporation, Sectra Medical Systems, Planmed, Fuji Medical Systems, IMS Giotto, and Carestream. The Company currently faces direct competition in its CAD business from Hologic, Inc. and imaging equipment manufacturers such as GE Healthcare, Siemens Medical, and Philips Medical Systems. The Company's systems are medical devices subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act with potentially costs for compliance.
» More Articles for NAS:ICAD

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: MCP, ICAD, BODY, VVTV, MCRI Sep 03 2012 
Weekly CFO Buys Highlight: BWEN, SGGH, ICAD, CMLS, MCP Aug 27 2012 
icad inc. Reports Operating Results (10-Q) Nov 09 2010 
icad inc. Reports Operating Results (10-Q) Aug 06 2010 
icad inc. (icad) Executive VP of Finance, CFO Darlene M Deptula-hicks sells 25,000 Shares Mar 11 2010 
icad inc. Reports Operating Results (10-Q) Aug 10 2009 
icad inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
iCAD to Host Fourth Quarter and Full Year 2015 Financial Results Conference Call on Tuesday, March... Feb 02 2016
iCad Completes Acquisition Of VuCOMP's Cancer Detection Portfolio Jan 13 2016
iCAD Expands Use of the Xoft Electronic Brachytherapy System in Europe, Asia and Australia Dec 16 2015
ICAD INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of... Dec 09 2015
iCAD Appoints Andrew Sassine to Board of Directors Dec 09 2015
ICAD INC Financials Dec 08 2015
Researchers to Present Updated Data Regarding Intraoperative Radiation Therapy with the Xoft System... Dec 08 2015
Capturing Changes in Investor Sentiments - Research on TransAtlantic Petroleum, InfuSystem Holdings,... Dec 04 2015
Do Hedge Funds Love Hutchinson Technology Incorporated (HTCH)? Dec 02 2015
iCAD Featuring New Technology for Automated Breast Density Assessment and Showcasing Solutions for... Nov 30 2015
UCP Inc (UCP): Are Hedge Funds Right About This Stock? Nov 27 2015
Is Emmis Communications Corporation (EMMS) A Good Stock To Buy? Nov 23 2015
iCAD To Present At The LD Micro "Main Event" Microcap Conference Nov 23 2015
iCAD Reports Use Of Xoft® Axxent® Electronic Brachytherapy System In The Treatment Of More Than... Nov 23 2015
iCAD's Xoft System Selected as a Popular Science Magazine "Best of What's New" Award Winner for 2015 Nov 18 2015
ICAD INC Files SEC form 10-Q, Quarterly Report Nov 04 2015
ICAD: Q3 Results Inline. More Clarity on Reimbursement Soon Nov 03 2015
ICAD INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 29 2015
Researchers to Present Up to 5-Year Positive Clinical Data Supporting Use of Xoft System for... Oct 19 2015
iCAD Launches National Educational Program to Increase Awareness of the Effective Use of Electronic... Sep 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK